Company intelligence / Profile preview
Positif Life Sciences
- Ownership
- Private
- Development stage
- Other
Overview
Positif Life Sciences is a fully commercial-stage, ISO & GMP-certified pharmaceutical manufacturer offering a broad portfolio of generic and branded medicines across India, mainly focused on small molecule drugs for infectious disease, metabolic disorders, and other therapeutic areas. No clinical trial or investigational drug results found
- Therapeutic areas
- EndocrinologyRheumatologyInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascular
- Modalities
- Small moleculeProteinPeptidesInjectable drugs (includes sterile products)SyrupsCream/Ointment
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Positif Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Positif Life Sciences.